200 base MAX but high expectations for pull thru after exceeding expectations tremendously since approved. Commission earnings used to be a thing to consider- used to be high, now they have rolled out individual goals in a rare disease with 4000 patients where many of the eligible patients are either on drug or have DC’d due to side effects eliminating potential to truly earn anymore. OG group has golden handcuffs from stock being fully vested from 2021 but that will only suffice for so long with less than 14,000 a quarter at 100% attainment and an Individual goal penalizing your top peformersCan anyone comment on this company these days? How's the culture? Whats a reasonable base?